Abstract

HSD9 Access to Precision Medicine in Mexico: Differences of Therapy Patterns for ALK+ and EGFR+ Non-Small Cell Lung Cancer (NSCLC) Patients

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract 599: Investigation of PD-L1 expression in circulating tumor cells isolated using the Parsortix system in metastatic lung and breast cancer patients
Mariacristina Ciccioli ... Anne-Sophie Pailhes-Jimenez
American Journal of Cancer | VOL. 81
Mariacristina Ciccioli, et. al.Mariacristina Ciccioli ... Anne-Sophie Pailhes-Jimenez
01 Jul 2021
Abstract PO-107: Racial differences in survival among advanced-stage non-small cell lung cancer patients who received immunotherapy: An analysis of the U.S. National Cancer Database (NCDB)
Anjali Gupta ... Tomi Akinyemiju
Cancer Epidemiology Biomarkers & Prevention | VOL. 31
Anjali Gupta, et. al.Anjali Gupta ... Tomi Akinyemiju
01 Jan 2021
Factors affecting treatment in small cell and non-small cell lung cancer patients.
Phuong Ngo ... Goetz H Kloecker
Journal of Clinical Oncology | VOL. 37
Phuong Ngo, et. al.Phuong Ngo ... Goetz H Kloecker
20 Sep 2019
Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia
Aaron Winter ... Stéphanie Chevalier
Clinical nutrition (Edinburgh, Scotland) | VOL. 31
Aaron Winter, et. al.Aaron Winter ... Stéphanie Chevalier
29 May 2012
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers